List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 98 studies with search of: lymphoma [CONDITION] AND "Phase III" [PHASE] | DLBCL OR "aggressive lymphoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Enrolling by invitation Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
Condition: Diffuse Large B-Cell Lymphoma
Intervention: Biological: NKM injection
2 Recruiting Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: RAD001;   Drug: Placebo
3 Active, not recruiting A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-Cell Lymphoma: NHL-13
Conditions: Diffuse Large B-Cell Lymphoma (DLBCL);   Follicular NHL Grade 3b
Intervention: Drug: Rituximab
4 Recruiting Early on-Therapy PET at First-Line Treatment in Diffuse Large B-Cell Lymphoma Stage IIB-IV
Condition: Diffuse Large-Cell Lymphoma
Intervention: Procedure: PET scan
5 Recruiting Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma;   IPI≥2
Interventions: Drug: Rituximab;   Drug: Ciclofosfamide;   Drug: Doxorubicina;   Drug: Vincristina;   Drug: Prednisone;   Drug: Pegfilgrastim;   Drug: Mitoxantrone;   Drug: ARA-C;   Drug: Lenograstim;   Drug: BCNU;   Drug: VP-16;   Procedure: ASCT
6 Terminated ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large Cell Lymphoma
Interventions: Drug: rituximab;   Drug: doxorubicin;   Drug: cyclophosphamide
7 Active, not recruiting R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large Cell Lymphoma
Interventions: Drug: R-CHOP21;   Drug: R-CHOP14;   Drug: Darbepoetin alfa
8 Completed ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Age-Adjusted IPI of 1
Condition: Diffuse Large-Cell Lymphoma
Interventions: Drug: rituximab;   Drug: doxorubicin;   Drug: cyclophosphamide
9 Active, not recruiting Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: vinblastine
10 Active, not recruiting Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: melphalan;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: mitoxantrone hydrochloride;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
11 Active, not recruiting Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: vincristine sulfate;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
12 Suspended GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: sargramostim;   Drug: vincristine;   Procedure: Intervention/procedure;   Procedure: antibody therapy;   Procedure: biological therapy;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: cytokine therapy;   Procedure: monoclonal antibody therapy;   Procedure: non-specific immune-modulator therapy;   Procedure: therapeutic procedure;   Procedure: tumor cell derivative vaccine;   Procedure: vaccine therapy
13 Recruiting Comparison of HD Chemotherapy Followed by Auto-Transplant and R-CHOP in High Risk Patients With DLBCL.
Condition: Diffuse Large B Cells Non-Hodgkin's Lymphomas
Interventions: Drug: Rituximab-HDS;   Drug: Rituximab-CHOP
14 Completed Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
15 Active, not recruiting Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate
16 Recruiting Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas
Condition: Lymphoma, High-Grade
Interventions: Drug: (R-)CHOP protocol;   Drug: B-ALL protocol
17 Terminated Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
Condition: CD20-Positive Large B-Cell Lymphoma
Interventions: Drug: ACVBP;   Drug: ACE;   Drug: rituximab;   Procedure: Autologous stem cell transplant
18 Not yet recruiting Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Lymphoma, Large-Cell, Diffuse
Interventions: Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
19 Active, not recruiting Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R
Condition: Lymphoma, Large Cell, Diffuse
Interventions: Drug: Zevalin Therapeutic Regimen;   Other: Observation
20 Completed Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: vincristine sulfate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services